Segment Information (Tables)
|
6 Months Ended |
Jun. 30, 2022 |
Segment Reporting [Abstract] |
|
Schedule of reportable business segment information |
Reportable business segment information is as follows (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
2022 |
|
2021 |
|
2022 |
|
2021 |
Net sales: |
|
|
|
|
|
|
|
Asia |
$ |
47,382 |
|
|
$ |
43,536 |
|
|
$ |
93,492 |
|
|
$ |
79,291 |
|
Europe |
17,099 |
|
|
21,455 |
|
|
38,876 |
|
|
43,655 |
|
North America |
34,082 |
|
|
37,372 |
|
|
70,063 |
|
|
75,134 |
|
Latin America and Other |
5,598 |
|
|
6,615 |
|
|
12,224 |
|
|
13,319 |
|
Total net sales |
104,161 |
|
|
108,978 |
|
|
214,655 |
|
|
211,399 |
|
|
|
|
|
|
|
|
|
Contribution margin (1): |
|
|
|
|
|
|
|
Asia |
21,432 |
|
|
18,463 |
|
|
43,371 |
|
|
33,782 |
|
Europe |
6,595 |
|
|
6,588 |
|
|
10,968 |
|
|
13,384 |
|
North America |
12,300 |
|
|
16,259 |
|
|
25,019 |
|
|
31,699 |
|
Latin America and Other |
2,294 |
|
|
3,762 |
|
|
5,195 |
|
|
7,394 |
|
Total contribution margin |
42,621 |
|
|
45,072 |
|
|
84,553 |
|
|
86,259 |
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses (2) |
36,866 |
|
|
35,586 |
|
|
77,489 |
|
|
69,138 |
|
Operating income |
5,755 |
|
|
9,486 |
|
|
7,064 |
|
|
17,121 |
|
|
|
|
|
|
|
|
|
Other income (loss), net |
(442) |
|
|
529 |
|
|
(756) |
|
|
(1,404) |
|
Income before provision for income taxes |
$ |
5,313 |
|
|
$ |
10,015 |
|
|
$ |
6,308 |
|
|
$ |
15,717 |
|
_________________________________________
(1) Contribution margin consists of net sales less cost of sales and volume incentives expense. (2) Service fees in China totaled $3.9 million and $8.8 million for the three and six-month periods ended June 30, 2022, respectively, compared to $3.7 million and $6.5 million for the three and six-month periods ended June 30, 2021. These service fees are included in selling, general and administrative expenses.
|
Schedule of consolidated net sales revenue by geographical locations |
From an individual country/region perspective, the United States, South Korea and Taiwan comprise 10 percent or more of consolidated net sales for the three and six-month periods ended June 30, 2022 and 2021, as follows (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
2022 |
|
2021 |
|
2022 |
|
2021 |
Net sales: |
|
|
|
|
|
|
|
United States |
$ |
31,483 |
|
|
$ |
34,378 |
|
|
$ |
64,712 |
|
|
$ |
69,298 |
|
South Korea |
14,465 |
|
|
17,546 |
|
|
28,118 |
|
|
32,355 |
|
Taiwan |
11,933 |
|
|
4,730 |
|
|
21,683 |
|
|
7,499 |
|
Other |
46,280 |
|
|
52,324 |
|
|
100,142 |
|
|
102,247 |
|
|
$ |
104,161 |
|
|
$ |
108,978 |
|
|
$ |
214,655 |
|
|
$ |
211,399 |
|
|
Schedule of revenue generated by each of the Company's product lines |
Net sales generated by each of our product lines is set forth below (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
2022 |
|
2021 |
|
2022 |
|
2021 |
Asia |
|
|
|
|
|
|
|
General health |
$ |
12,319 |
|
|
$ |
12,698 |
|
|
$ |
25,305 |
|
|
$ |
23,990 |
|
Immune |
781 |
|
|
382 |
|
|
2,125 |
|
|
585 |
|
Cardiovascular |
13,242 |
|
|
12,260 |
|
|
26,872 |
|
|
22,163 |
|
Digestive |
10,990 |
|
|
7,747 |
|
|
20,026 |
|
|
14,618 |
|
Personal care |
2,083 |
|
|
5,290 |
|
|
4,626 |
|
|
7,814 |
|
Weight management |
7,967 |
|
|
5,159 |
|
|
14,538 |
|
|
10,121 |
|
|
47,382 |
|
|
43,536 |
|
|
93,492 |
|
|
79,291 |
|
Europe |
|
|
|
|
|
|
|
General health |
$ |
7,328 |
|
|
$ |
9,667 |
|
|
$ |
16,524 |
|
|
$ |
19,139 |
|
Immune |
1,443 |
|
|
1,818 |
|
|
4,074 |
|
|
3,834 |
|
Cardiovascular |
2,150 |
|
|
2,836 |
|
|
4,783 |
|
|
5,828 |
|
Digestive |
4,481 |
|
|
5,567 |
|
|
10,072 |
|
|
11,107 |
|
Personal care |
1,209 |
|
|
999 |
|
|
2,442 |
|
|
2,425 |
|
Weight management |
488 |
|
|
568 |
|
|
981 |
|
|
1,322 |
|
|
17,099 |
|
|
21,455 |
|
|
38,876 |
|
|
43,655 |
|
North America |
|
|
|
|
|
|
|
General health |
$ |
14,954 |
|
|
$ |
16,349 |
|
|
$ |
30,268 |
|
|
$ |
32,619 |
|
Immune |
4,061 |
|
|
4,101 |
|
|
8,933 |
|
|
8,975 |
|
Cardiovascular |
3,893 |
|
|
4,010 |
|
|
7,735 |
|
|
8,235 |
|
Digestive |
9,044 |
|
|
10,016 |
|
|
17,638 |
|
|
19,479 |
|
Personal care |
1,389 |
|
|
1,834 |
|
|
3,564 |
|
|
3,653 |
|
Weight management |
741 |
|
|
1,062 |
|
|
1,925 |
|
|
2,173 |
|
|
34,082 |
|
|
37,372 |
|
|
70,063 |
|
|
75,134 |
|
Latin America and Other |
|
|
|
|
|
|
|
General health |
$ |
1,597 |
|
|
$ |
1,873 |
|
|
$ |
3,415 |
|
|
$ |
3,848 |
|
Immune |
755 |
|
|
697 |
|
|
1,516 |
|
|
1,508 |
|
Cardiovascular |
455 |
|
|
425 |
|
|
812 |
|
|
903 |
|
Digestive |
2,551 |
|
|
3,001 |
|
|
5,392 |
|
|
5,872 |
|
Personal care |
80 |
|
|
398 |
|
|
721 |
|
|
743 |
|
Weight management |
160 |
|
|
221 |
|
|
368 |
|
|
445 |
|
|
5,598 |
|
|
6,615 |
|
|
12,224 |
|
|
13,319 |
|
|
$ |
104,161 |
|
|
$ |
108,978 |
|
|
$ |
214,655 |
|
|
$ |
211,399 |
|
|
Schedule of consolidated property, plant and equipment by geographical locations |
From an individual country perspective, only the United States comprised 10 percent or more of consolidated property, plant and equipment as follows (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2022 |
|
December 31, 2021 |
Property, plant and equipment: |
|
|
|
United States |
$ |
45,036 |
|
|
$ |
46,595 |
|
Other |
4,063 |
|
|
4,262 |
|
Total property, plant and equipment, net |
$ |
49,099 |
|
|
$ |
50,857 |
|
|
Schedule of assets per segment |
Total assets per segment is set forth below (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2022 |
|
December 31, 2021 |
Assets: |
|
|
|
Asia |
$ |
91,762 |
|
|
$ |
104,659 |
|
Europe |
14,771 |
|
|
15,486 |
|
North America |
119,018 |
|
|
131,207 |
|
Latin America and Other |
7,508 |
|
|
7,522 |
|
Total assets |
$ |
233,059 |
|
|
$ |
258,874 |
|
|